Trials / Unknown
UnknownNCT05305729
Metabolic FingerPrinting
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Arcensus GmbH · Industry
- Sex
- All
- Age
- 2 Months
- Healthy volunteers
- Not accepted
Summary
The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2022-03-31
- Last updated
- 2022-03-31
Locations
5 sites across 2 countries: Albania, Pakistan
Source: ClinicalTrials.gov record NCT05305729. Inclusion in this directory is not an endorsement.